Pain and Inflammation Research

Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.

Pain and Inflammation Research Products Areas

Products for Pain and Inflammation Research - Page 93

Cat.No. Product Name Information/Activity
BCC6668 U-54494A hydrochloride 112465-94-8
BCC6614 nor-Binaltorphimine dihydrochloride Norbinaltorphimine dihydrochloride is a potent and selective κ opioid receptor antagonist.
BCC6799 DIPPA hydrochloride 155512-52-0
BCC7003 GNTI dihydrochloride 351183-88-5
BCC6308 ML 190 1355244-02-8
BCC6958 DAMGO DAMGO is a μ-opioid receptor (μ-OPR ) selective agonist with a Kd of 3.46 nM for native μ-OPR.
BCC1008 Endomorphin-1 Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM.
BCC5697 Endomorphin-2 Endomorphin 2, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM.
BCC6000 Fentanyl citrate 990-73-8
BCC4920 Meptazinol HCl Meptazinol is a unique centrally active opioid analgesic, which inhibits [3H]dihydromorphine binding with IC50 of 58 nM.